IFE Study: Liver transplant recipient Initiative: Feasibility study to Enhance cardio-metabolic health

Not Applicable

Completed

• Conditions: iver Transplant Recipients; Cardiometabolic health; Liver Transplant Recipients; Diet and Nutrition - Obesity; Cardiovascular - Other cardiovascular diseases; Physical Medicine / Rehabilitation - Other physical medicine / rehabilitation; Oral and Gastrointestinal - Other diseases of the mouth, teeth, oesophagus, digestive system including liver and colon; Metabolic and Endocrine - Other metabolic disorders

• Registration Number: ACTRN12617001260314
• Lead Sponsor: Princess Alexandra Hospital

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2017-08-30
• Study Completion: 2018-07-31
• Last Update Posted: 4 December 2018

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 35

Inclusion Criteria

Participants will be considered eligible when they meet the following inclusion criteria:
a) Adults under the care of Queensland Liver Transplant Service (QLTS), >6mths post-transplant, expected survival >1year.
b) Have current access to a mobile phone or computer hardware with internet access and capabilities for webcam attachment; and
c) Provide written informed consent.

Exclusion Criteria

This study will exclude participants that do not satisfy the above inclusion criteria, or:
Have a food allergy or dietary restriction that results in MedDiet being deemed inappropriate
Have a physical disability that whereby an increase in physical activity would be deemed inappropriate
Are deemed unsafe to participate by their Hepatologist or Transplant Surgeon
Are non-English speaking; and/or unable to read and write in English

Study & Design

• Study Type: Interventional
• Study Design: Not specified